AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nichi-Iko Pharmaceutical Co., Ltd.
  3. Financials
  4. Cost of revenue

Nichi-Iko Pharmaceutical Co., Ltd.【JP:E00963】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2022175,094+4.86%
Mar 31, 2021166,973+9.31%
Mar 31, 2020152,756+14.48%
Mar 31, 2019133,434+7.68%
Mar 31, 2018123,914+16.20%
Mar 31, 2017106,637+18.49%
Mar 31, 201689,999+12.59%
Mar 31, 201579,935

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)